X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet   (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 559.9
Mkt Cap Rs m 1,347,541
Vol '000 224.1
P/E X 45.6
P/CF X 14.8
EPS (TTM) Rs 12.3
% ch % 2.7
No. of shares m 2,406.75
% ch week % 0.1
% ch 1-mth % -0.7
% ch 12-mth % -3.8
52 week H/L Rs 608.6/433.2
(As on Jul 20, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs8486531,0741,201842 
Low Rs554493570706572 
Sales per share (Unadj.) Rs109.177.6132.3118.4131.6 
Earnings per share (Unadj.) Rs28.815.221.923.532.7 
Diluted earnings per shareRs12.413.118.923.532.6 
Cash flow per share (Unadj.) Rs32.117.127.727.838.0 
Dividends per share (Unadj.) Rs5.001.503.001.003.50 
Adj. dividends per shareRs2.151.292.581.003.49 
Dividend yield (eoy) %0.70.30.40.10.5 
Book value per share (Unadj.) Rs144.789.4135.2137.1152.7 
Adj. book value per shareRs62.377.0116.4137.0152.2 
Shares outstanding (eoy) m1,035.582,071.162,071.162,406.602,399.26 
Bonus/Rights/Conversions  -B1:1--- 
Price / Sales ratio x6.47.46.28.15.4 
Avg P/E ratio x24.337.837.540.621.6 
P/CF ratio (eoy) x21.933.429.734.318.6 
Price / Book Value ratio x4.86.46.17.04.6 
Dividend payout %17.49.913.74.310.7 
Avg Mkt Cap Rs m725,9421,186,7751,703,0112,294,8131,696,877 
No. of employees `00014.014.0NA14.717.5 
Total wages/salary Rs m15,34520,74445,02647,72349,023 
Avg. sales/employee Rs Th8,071.311,486.0NM19,317.218,028.3 
Avg. wages/employee Rs Th1,096.11,481.7NM3,236.12,798.8 
Avg. net profit/employee Rs Th2,130.82,243.9NM3,836.94,479.5 
SUN PHARMA INCOME DATA
Net Sales Rs m112,999160,804273,920284,870315,784 
Other income Rs m2,7632,6475,4776,5836,232 
Total revenues Rs m115,761163,451279,397291,453322,016 
Gross profit Rs m48,96272,87378,66781,583100,893 
Depreciation Rs m3,3624,09211,94710,37512,648 
Interest Rs m4324425,7905,2323,998 
Profit before tax Rs m47,93270,98666,40772,55890,479 
Minority Interest Rs m-4,863-7,375-9,36300 
Prior Period Items Rs m00-1261599 
Extraordinary Inc (Exp) Rs m-4,783-25,174-2,378-6,8520 
Tax Rs m8,4567,0229,1479,13812,116 
Profit after tax Rs m29,83131,41545,39456,58378,462 
Gross profit margin %43.345.328.728.631.9 
Effective tax rate %17.69.913.812.613.4 
Net profit margin %26.419.516.619.924.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m115,030186,865288,782299,413329,537 
Current liabilities Rs m28,41359,896153,294131,440178,870 
Net working cap to sales %76.779.049.559.047.7 
Current ratio x4.03.11.92.31.8 
Inventory Days Days8371768279 
Debtors Days Days7850688783 
Net fixed assets Rs m50,77158,242151,694180,477204,766 
Share capital Rs m1,0362,0712,0712,4072,399 
"Free" reserves Rs m136,274163,019278,009327,418363,997 
Net worth Rs m149,897185,250280,080329,825366,397 
Long term debt Rs m1,15348713,59831,10314,361 
Total assets Rs m205,827293,708501,601555,303614,102 
Interest coverage x112.1161.612.514.923.6 
Debt to equity ratio x0000.10 
Sales to assets ratio x0.50.50.50.50.5 
Return on assets %14.710.810.211.113.4 
Return on equity %19.917.016.217.221.4 
Return on capital %25.620.920.519.724.8 
Exports to sales %17.014.116.913.90 
Imports to sales %4.73.64.53.10 
Exports (fob) Rs m19,23822,71346,23539,5720 
Imports (cif) Rs m5,3535,77912,2298,8820 
Fx inflow Rs m19,61523,16848,70642,17144,118 
Fx outflow Rs m7,87712,62925,56421,58324,484 
Net fx Rs m11,73910,53923,14220,58819,634 
SUN PHARMA CASH FLOW
From Operations Rs m 33,566 39,592 56,157 66,859 70,822 
From Investments Rs m -26,351 -23,668 -28,657 -43,716 -42,216 
From Financial Activity Rs m -6,650 5,066 -11,865 -18,885 -22,854 
Net Cashflow Rs m 565 20,990 15,635 8,482 6,107 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON LTD  

Compare SUN PHARMA With:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON LTD  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; IT Stocks Lead Gains(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in above the dotted line.

Views on news

SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, SUN PHARMA has posted a net profit of Rs 16 bn (up 12.0% YoY). Sales on the other hand came in at Rs 70 bn (down 2.2% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - ACTAVIS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS